A new study finds Black Medicare beneficiaries with early-stage non–small cell lung cancer (NSCLC) continues to receive curative treatment at lower rates than White patients, highlighting ongoing ...
The past 30 years have seen tremendous progress in our fundamental understanding of lung cancer and the development of new treatment strategies,” senior researcher Dr. Cary Gross, a professor at Yale ...
Five-year survival rates are among the lowest of all cancers, at about 25%. But when caught early enough – through annual CT ...
Key combination for the treatment of Small Cell Lung Cancer MADRID and CAMBRIDGE, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage ...
Racial disparities persist in receipt of curative treatment for early-stage non-small cell lung cancer (NSCLC), according to ...
This March, join the Alliance for Clinical Trials in Oncology (Alliance) and the Alliance Foundation Trials (AFT) in spotlighting colorectal cancer, the second leading cause of cancer-related death in ...
The AIG Hospitals today announced the launch of the ZAP-X Gyroscopic Neuro-Radiosurgery Platform, the first installation of its kind in South India and only the second in the country, marking a major ...
Hyderabad: AIG Hospitals launched the ZAP-X Gyroscopic Neuro-Radiosurgery Platform, the first installation of its kind in South India and only the second in the country. There are 36 of these ...
CdM | Oryzon Genomics has announced that the Mexican Patent Office has issued a decision to grant patent application MX/a/2021/011610, entitled ‘Combinations ...
Intent-to-treat median PFS was 10.2 months with nivolumab/ipilimumab versus 6.3 months with added SBRT, with 12-month PFS 47.8% versus 34.9% (HR 1.20; P=.56). Per-protocol analysis after four ...
In oligometastatic castration-resistant prostate cancer, the rationale to use local SBRT is improved disease control.
Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...